Literature DB >> 26300219

To reduce or abstain? Substance use goals in the treatment of veterans with substance use disorders and comorbid PTSD.

Brian E Lozano1,2, Daniel F Gros1,2, Therese Killeen2, Maryanne Jaconis2, Francis M Beylotte2, Stephen Boyd2, Sudie E Back1,2.   

Abstract

BACKGROUND: Posttraumatic stress disorder (PTSD) and substance use disorders (SUD) frequently co-occur. Previous research demonstrates the utility of goals in attaining improved SUD outcomes, however, no previous studies have examined goal choices in the context of integrated treatment for comorbid PTSD and SUD.
OBJECTIVES: The present study investigated correlates of treatment entry goals to either reduce or abstain from substance use.
METHODS: Participants (N = 60) were treatment-seeking veterans with current PTSD and SUD. Participants completed self-report and clinician-rated measures of substance use, PTSD, and affective symptoms as part of a larger randomized controlled trial.
RESULTS: Half (30/60) of participants endorsed a treatment entry goal to reduce substance use (reducers). Compared to participants who endorsed a treatment entry goal of abstinence (abstainers), reducers were significantly younger, more likely to be employed, more likely to have served in recent military conflicts (Operations Enduring/Iraqi Freedom), and endorsed significantly fewer symptoms of alcohol dependence. CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE: The findings demonstrate clinically relevant differences based on treatment entry goals, suggesting that individuals are often able to choose conceivably appropriate treatment goals based, most notably, on the severity of their SUD. Collaboratively engaging patients in establishing treatment goals that are consistent with their beliefs and desires in conjunction with empirical findings is particularly relevant in the context of treatment for SUD and PTSD where many patients are ambivalent about treatment and attrition is common. © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Year:  2015        PMID: 26300219      PMCID: PMC4867466          DOI: 10.1111/ajad.12263

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  16 in total

Review 1.  Misunderstanding analysis of covariance.

Authors:  G A Miller; J P Chapman
Journal:  J Abnorm Psychol       Date:  2001-02

2.  Improving PTSD/substance abuse treatment in the VA: a survey of providers.

Authors:  Lisa M Najavits; Sonya B Norman; Daniel Kivlahan; Thomas R Kosten
Journal:  Am J Addict       Date:  2010 May-Jun

3.  Posttraumatic Stress Disorder and Co-Occurring Substance Use Disorders: Advances in Assessment and Treatment.

Authors:  Jenna L McCauley; Therese Killeen; Daniel F Gros; Kathleen T Brady; Sudie E Back
Journal:  Clin Psychol (New York)       Date:  2012-09-01

Review 4.  Motivation for treatment: a review with special emphasis on alcoholism.

Authors:  William R Miller
Journal:  Psychol Bull       Date:  1985-07       Impact factor: 17.737

5.  Predictors of treatment outcome for alcoholics treated by individualized behavior therapy.

Authors:  S A Maisto; M B Sobell; L C Sobell
Journal:  Addict Behav       Date:  1980       Impact factor: 3.913

6.  Slow and steady wins the race: a randomized clinical trial of acceptance and commitment therapy targeting shame in substance use disorders.

Authors:  Jason B Luoma; Barbara S Kohlenberg; Steven C Hayes; Lindsay Fletcher
Journal:  J Consult Clin Psychol       Date:  2011-10-31

7.  Abstinence and moderate use goals in the treatment of marijuana dependence.

Authors:  Brian E Lozano; Robert S Stephens; Roger A Roffman
Journal:  Addiction       Date:  2006-11       Impact factor: 6.526

Review 8.  Substance use disorders in patients with posttraumatic stress disorder: a review of the literature.

Authors:  L K Jacobsen; S M Southwick; T R Kosten
Journal:  Am J Psychiatry       Date:  2001-08       Impact factor: 18.112

Review 9.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

10.  Toward an improved model of treating co-occurring PTSD and substance use disorders.

Authors:  Sudie E Back
Journal:  Am J Psychiatry       Date:  2010-01       Impact factor: 18.112

View more
  7 in total

1.  Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial.

Authors:  Lesia M Ruglass; Teresa Lopez-Castro; Santiago Papini; Therese Killeen; Sudie E Back; Denise A Hien
Journal:  Psychother Psychosom       Date:  2017-05-11       Impact factor: 17.659

2.  Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans.

Authors:  Sudie E Back; Therese Killeen; Christal L Badour; Julianne C Flanagan; Nicholas P Allan; Elizabeth Santa Ana; Brian Lozano; Kristina J Korte; Edna B Foa; Kathleen T Brady
Journal:  Addict Behav       Date:  2018-11-27       Impact factor: 3.913

Review 3.  Expanding the continuum of substance use disorder treatment: Nonabstinence approaches.

Authors:  Catherine E Paquette; Stacey B Daughters; Katie Witkiewitz
Journal:  Clin Psychol Rev       Date:  2021-11-26

4.  Alcohol Use Disorder and Posttraumatic Stress Disorder: An Introduction.

Authors:  Sudie E Back; Jennifer L Jones
Journal:  Alcohol Clin Exp Res       Date:  2018-03-15       Impact factor: 3.455

Review 5.  Behavioral Treatments for Alcohol Use Disorder and Post-Traumatic Stress Disorder.

Authors:  Julianne C Flanagan; Jennifer L Jones; Amber M Jarnecke; Sudie E Back
Journal:  Alcohol Res       Date:  2018

6.  Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder.

Authors:  Emma A van Reekum; Tea Rosic; Jacqueline Hudson; Nitika Sanger; David C Marsh; Andrew Worster; Lehana Thabane; Zainab Samaan
Journal:  Biol Sex Differ       Date:  2020-04-23       Impact factor: 5.027

Review 7.  Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.

Authors:  Neil P Roberts; Pamela A Roberts; Neil Jones; Jonathan I Bisson
Journal:  Cochrane Database Syst Rev       Date:  2016-04-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.